Dresbuxelimab

• Description:

  Dresbuxelimab (AK-119) is an IgG-κ monoclonal antibody targeting CD73. The expression system is usually CHO (Chinese Hamster Ovary) cells[1].

• Product Name Alternative:

  AK-119

• UNSPSC:

  12352203

• Target:

  CD73

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/dresbuxelimab.html

• Purity:

  98.00

• Solubility:

  10 mM in DMSO

• Smiles:

  [Dresbuxelimab]

• Molecular Weight:

  (146.8 kDa)

• References & Citations:

  [1]Dresbuxelimab. IMGT.

• Shipping Conditions:

  Dry Ice

• Storage Conditions:

  Store at -80°C for 2 years

• Scientific Category:

  Inhibitory Antibodies

• Clinical Information:

  Phase 2

• CAS Number:

  [2550560-20-6]